ZEB2 and colorectal carcinoma: The L6 CRC used in this study displayed several features of CMS4 tumors (ZEB2 overexpression, TGF-β activation, EMT, microsatellite stability) but lacks other features of CMS4 such as increased stromal content as compared to L5 and L7.